Elevance Health Financials - Benzinga

Elevance Health Inc

ELVNYSE

Trade with Public

Trade with Public

$398.56

-3.87-0.96%

가까이에: Sep 23, 5:00 PM EST

$398.56

N/A

시간외: 4:19 PM EST

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 배당금 비교 옵션 주식 보고서

Elevance Health Financials

Elevance Health (ELV) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Elevance Health Affirms FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est

Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..

Benzinga Newsdesk

PRO
Elevance Health Affirms FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est

Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..

Benzinga Newsdesk

These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings

Elevance Health Inc. (NYSE:ELV) reported strong Q2 results and raised full-year guidance. Analysts have adjusted price targets for ELV stock.

Avi Kapoor

Elevance Health's Small Outlook Boost Disappoints, Stock Sinks

Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a conservative guidance raise.

Vandana Singh

Earnings Scheduled For July 15, 2026

Companies Reporting Before The Bell • VCI Global (NASDAQ:VCIG) is estimated to report earnings for its Fiscal Year 2025. • PNC Financial Services Gr (NYSE:PNC) is projected to report quarterly earnings at $4.43 per

Benzinga Insights

PRO
Elevance Health Sees FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est

Elevance Health (NYSE:ELV) FY2026 EPS expected to be more than $20.10 vs $20.26 Est..

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved